Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Cover
Financial Statements
Notes to Financial Statements
Accounting Policies
- SIGNIFICANT ACCOUNTING POLICIES (Policies)
Notes Tables
Notes Details

REVENUES (Details Narrative)

REVENUES (Details Narrative) $ in Millions	Sep. 30, 2024 USD ($)
Disaggregation of Revenue [Line Items]
Gross-to-net allowances	$ 4.8
Accounts Receivable [Member]
Disaggregation of Revenue [Line Items]
Gross-to-net allowances	1.0
Accrued Liabilities [Member]
Disaggregation of Revenue [Line Items]
Gross-to-net allowances	$ 3.8

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details